Trophy Investing Recommendation 

eWellness’ Digital Therapeutics Disruptive to Physical Therapy Industry

By Michael Markowski, July 12, 2016

The eWellness Healthcare Corporation, (OTCQB: EWLL) (the ”Company”), has emerged to digitally disrupt the brick and mortar physical therapist industry.  The Company’s digital products and technology have put it into the position to soon be recognized by investors as a first-mover company in digital therapeutics.  Significantly, eWellness is also the first to enable physical therapists to offer digital treatments that are insurance reimbursable.  The week ended July 11, 2016 the share price of eWellness fell to a new 52-week low.   For these reasons Trophy Investing has initiated coverage and eWellness has been added to the Trophy Investing recommended list. 

Besides disrupting the brick and mortar physical therapy industry the Company is positioned to capitalize from the rapidly changing demographics for and the growth of the physical therapy industry.  The aging baby boomer population and the changes by doctors as reported by Amn Healthcare pertaining to when a patient should have hip and knee replacements has resulted in both skyrocketing.  Predictions abound regarding the current shortage of physical therapists, and the increasing shortage predicted for the foreseeable future.  See “Physical Therapists in Short Supply”.  The chart below depicts that the combined number of hip and knee replacements has been growing briskly since 2005 and will reach four million per annum by 2030.


Following a preliminary analysis of the eWellness PHZIO product offering, my conclusion is that the Company is a bona fide digital disruptor.  The Company’s model will soon seriously disrupt the brick and mortar physical therapy industry.  The four minute-+ video below entitled, “Digital disruptor companies have the potential to get to $10 billion valuations quickly”, explains the process that digital disruptors must undergo to succeed — including UBER.   (A $10,000 investment into UBER in 2010 was valued for $105 million in 2015.)  Should the eWellness PHZIO product gain traction upon its Q4 2016 commercial launch, its share price and valuation has the potential to increase exponentially.   

The Company’s launch of its PHZIO digital therapeutic treatment and monitoring systems in the fourth quarter of 2016 will be of great benefit to physical therapists and their patients:

  • The ability for patients to receive physical therapy remotely will eliminate the costs and time required for visits to brick-and-mortar facilities.  PHZIO will also reduce the time spent for a patient to fully recover because patient protocol adherence and compliance rates are 20% higher than industry standards; 
  • Physical therapists will be able to significantly increase the number of patients that they see per day.  This will result in a significant increase in their incomes.  Physical therapists who must obtain doctorate degrees are among the lowest paid health care professionals in the U.S. at a median annual salary of $85,000 per annum. 

The Company’s initial PHZIO home physical therapy exercise platform has been designed to disrupt the $30 billion physical therapy and the $8 billion corporate wellness industries. PHZIO re-defines the way physical therapy can be delivered. PHZIO is the first real-time remotely monitored one-to-many physical therapy platform for home use. As a result of the real-time patient monitoring feature, the PHZIO platform is insurance reimbursable by payers such as Anthem Blue Cross and Blue Shield.  The Company’s platform is HIPAA compliant.    

PHZIO is a revolutionary Physical Therapy Delivery System:

Value Proposition

Through its PHZIO digital technology platform, eWellness provides a physical therapist (PT) the ability to scale their practices to substantially increase their take home pay.   The Company’s digital platform enables a PT to grow beyond the limits of a brick and mortar physical therapy practice?   Prior to PHZIO physical therapists could not scale their practices because the traditional office treatments were relegated to one-on-one sessions.   Additionally, industry profits per visit have steadily decreased by 27% since 2006 because of: (i) declining insurance reimbursements; (ii) growth constraints; and (iii) increased regulatory costs.  For these reasons the PTs who will soon become licensees of the PHZIO digital platform have an inherent competitive advantage over those who are not licensees.

PHZIO’s Value Proposition for Physical Therapy Practice (PTP) Licensees:

  • Enables PTP to increase the number of patient visits to at least 25 per day.
  • Enables PTP to increase quality of care.
  • Increases PTP revenue per square foot.
  • Increases revenue of PTP’s PTs. 
  • Reduces PTP’s costs and expenses.

Intellectual Property

An exclusive, perpetual license has been obtained by eWellness for its video management and streaming platform.  The platform records and stores each and every remote physical therapy video session to provide the backup for insurance reimbursement.  The platform enables the PT to have simultaneous two-way video interaction with a patient.  The Company has produced a proprietary portfolio of videos that cover more than 160 exercises. 

Communications between patients and the PT are conducted via texting and video messaging.  The photograph of the man exercising below is an excerpt from one of the Company’s proprietary exercise routine videos.  The photograph in the upper right corner is that of a woman mimicking the routine while watching the video from her home, while the physical therapist — depicted in the lower right corner — monitors the female patient’s exercise routine from his office in real-time.   


The Company has two highly experienced and well-known physical therapists on its team.  They are Darwin Fogt and Daniel Mills.  These two seasoned physical therapists should enable the Company to gain traction to recruit PTs during the fourth quarter of 2016 when the Company is expected to officially launch its PHZIO digital platform.     

CEO, Darwin Fogt, possesses vast experience and is an accomplished Physical Therapist:

  • Founded Evolution Physical Therapy, a state-of-the-art clinic in Los Angeles
  • Licensed Physical Therapist in New York and California
  • Specializes in neurological rehabilitation, orthopedic and sports medicine
  • Active in community outreach and educational programs in conjunction with the Los Angeles Clippers

Chairman of Advisory Board, Daniel Mills, MPT, is a well-known Utah-based practicing physical therapist ("PT"), and Vice President of the Private Practice Section of the American Physical Therapy Association ("APTA").  Mr. Mills is the Company’s national spokesperson to the APTA membership and other groups within the industry.

The APTA is an individual membership professional organization representing more than 93,000 member physical therapists (PTs), physical therapist assistants (PTAs), and students of physical therapy.  APTA seeks to improve the health and quality of life of individuals in society by advancing the physical therapist practice, education, and research, and by increasing awareness and understanding of physical therapy's role in the nation's health care system.

Summary Projections

According to what has been filed with the SEC, the Company’s plan over the next three to five years is to grow its base of digital PTs to 2,600.  This would represent less than 2% of all of the 225,000 practicing PT’s in the U.S.  Assuming that the Company can meet its recruitment goals for new PT licensees, it is projecting that it could potentially generate: 

  • A minimum of 8.1 million PHZIO sessions annually;
  • $111 million in annual revenue for eWellness;
  • Pre-tax profit margins of 82.90%; and
  • Annualized EBITA of $99 million.

Financials Summary

The final aspects of a company that I examine are its financial statements.  I waste no time on this activity until a company’s revenue, business model, and management have passed muster.  I have consistently found the balance sheets of development-stage companies to be upside down.  I cannot recall a single instance of a development-stage company having anything close to pristine financial statements.  Using financial statements as the primary screen to detect promising development-stage companies is an exercise in futility.  Further, I much prefer a company having negative financial statements, especially losses and a negative net worth or book value, over one that has not had a significant amount of capital previously invested.  Why?  There is great value in an entrepreneurial business having spent money and time to make mistakes prior to my having found them.  

The financial statements of eWellness are no different than a majority of the previous development-stage companies that I have examined.  Based on their financials filed with the SEC for the quarter ended March 31, 2016, to a casual observer it would appear that the company is on the verge of going out of business.  The Company reported an operating loss of $350,000.  However, the Company’s negative cash flow from operations for the quarter was only $28,000.  The Company’s negative net worth or the amount of its liabilities, which exceeded its assets, was approximately $1.7 million.  Approximately half of this amount, or $800,000, was attributable to accrued salaries that were owed to its officers and directors.  For a company that has published projections for gross margins nearing 90% and EBITA of $100 million by 2020 the burn rate and negative net worth are fairly innocuous.   

The price of eWellness shares has been very volatile for 2016, ranging from a high of $4.00 earlier in the year to a low of below $1.00 in July 2016.   The volatility that the shares have experienced is common because the shares trade on the obscure OTCQB exchange. Experience dictates that I can unequivocally state, the best opportunities for an investor to make ten times their money over periods of five years, or less, can be found among those companies having shares trading on the OTCQB and the other off-the-beaten-path exchanges.  This assumes that the investor follow a strict discipline of utilizing price limits to acquire the shares.  Trophy Investing provides an initial suggested buy limit price upon its recommending shares of any company.  Based on changes to the company’s fundamentals, the buy limit share price is raised or lowered by Trophy Investing.  

In addition to small and micro-cap companies being subject to the obscure exchanges the overall relative valuations of their share prices are at their lowest that I have seen in the 40 years.  This rare phenomenon has occurred from the SEC’s implementing of the Dodd Frank Act in 2012.  Dodd Frank has created a divergence in the share prices of large and small companies.  The 4-minute video below entitled, “Trophy Investing’s Search for the Best 100 Micro-cap Stocks” explains the divergence and the reasons this provides a once in a lifetime opportunity for investors to purchase the shares of small companies at absurdly low prices to populate a portfolio that could multiply in value very quickly.

The 4-minute and 43-second video below entitled, “Free Cash Flow Investing” reveals details about my simultaneously discovering and recommending two companies with share prices below $1 per share.  The shares of both companies were very illiquid and were not trading on the NASDAQ or NYSE when I found them.  Less than five years later the share prices of both companies had multiplied by at least 20 times and their share volumes had increased exponentially.   

Below is the 2-minute and 57-second video entitled, “Markowski, Visionary Analyst 2 of 5” which covers Senior Service/Almost Family and visionary investing.  The video provides details on the visionary analytical regimen that I utilized to finance and recommend the shares at a price of under $5 for an early- or venture-stage company.   This company is now traded on NASDAQ and has traded as high as $50 within the past 52 weeks.      

With the publication of this report, eWellness (EWLL) has been added to Trophy Investing’s list of recommendations.

Trophy Investing’s mission is to find and recommend the 100 best micro-cap and low-priced stocks worldwide.  Shares of the companies must have the potential to multiply in price within five years, or less.  Ongoing research coverage will be provided for a minimum of three years on each of the companies appearing on the Trophy Investing list of recommended companies.   Information about Free and Premium access to the Trophy Investing community is available at

Trophy Investing was founded by Michael Markowski — named by Fortune Magazine as one of its “50 Great Investors” — to capitalize on the divergence in the markets caused by the passage of the Dodd Frank Act.  From his research in April of 2016 Michael concluded that those companies defined as micro-caps that have share prices trading below $10, or market caps of below $100 million, were most recently at their lowest relative valuations since he entered the capital markets in 1977. 

Additional information about Trophy Investing is available at  Information about Michael Markowski is available at   


DISCLOSURE: This report has been prepared and distributed by Trophy Investing Incorporated (TI).  This report is based on sources that we consider reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. All information contained herein is subject to change without notice. This report is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of an investor.  Investors should consider whether any information in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. Statements included in this report may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues.  TI has not been compensated for the preparation of this report.   Readers should note that Michael Markowski, the author of this report is the brother of David Markowski who is the CFO of the company recommended herein.   TI and/or its affiliates may have a long or short position with respect to the publicly traded shares of the subject company covered in this report.  TI is not a broker-dealer and does not generate any investment banking or commission-based revenue with respect to the securities of the company described herein. Our professionals may provide oral or written market commentary that reflects opinions that are contrary to the opinions expressed in this report. The price and value of the investment referred to in this report may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Certain transactions, including those involving futures, options, and other derivatives, give rise to substantial risk and are not suitable for all investors. Our reports are disseminated primarily electronically, and, in some cases, in printed form. Electronic report is simultaneously available to all recipients in any form. The information contained in this report is not incorporated into the contents of our website and should be read independently thereof. Copyright 2016 Trophy Investing Incorporated.  No part of this material may be (i) copied, photocopied or duplicated in any for by any means or (ii) redistributed without the prior written consent of Trophy Investing Incorporated. 

©2016 Trophy Investing Incorporated